Reflujo vesicoureteral complejo. Revisión de nuestra serie

The overall per-ureter Dx/HA success rate was 77% after 3 months, although success rates varied widely among studies. Increased VUR grade negatively affected success rates, whereas COI, patient age, and injected Dx/HA volume were not significantly associated with treatment outcome after adjustment for VUR grade. There is a significant need for improved reporting of VUR treatments, including comparative studies of Dx/HA and other VUR treatments.

show abstract

Dextranomer/Hyaluronic Acid for Pediatric Vesicoureteral Reflux: Systematic Review

Routh

2010

View full text Add to dashboard Cite

show abstract

Tratamiento endoscópico del reflujo de vesicoureteral en pediatría: Experiencia preliminar con la inyección subureteral de coaptite®

Durban¹,

Sebastián²,

Delgado³

et al. 2006

Arch. Esp. Urol.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Reflujo vesicoureteral complejo. Revisión de nuestra serie

Abstract: We conclude that subureteral injection of different sustances (Teflon, Macroplastique or Deflux) is a useful treatment for most cases of vesicoureteral reflux. We propose it as first step of treatment.

Cited by 2 publications

References 22 publications

Dextranomer/Hyaluronic Acid for Pediatric Vesicoureteral Reflux: Systematic Review

Dextranomer/Hyaluronic Acid for Pediatric Vesicoureteral Reflux: Systematic Review

Tratamiento endoscópico del reflujo de vesicoureteral en pediatría: Experiencia preliminar con la inyección subureteral de coaptite®

Contact Info

Product

Resources

About